Executive Summary Access to advanced treatments like biopharmaceuticals is a critical challenge in conflict-affected regions such as Syria and Libya, where fragile healthcare systems struggle to meet patient needs. High costs, disrupted supply chains, and limited access to Western suppliers often leave patients without life-saving therapies.   India, recognized globally as the “pharmacy of the world”, has emerged as a reliable hub for affordable innovation. As a leading biopharmaceutica...